Given Imaging Bravo CF capsule delivery device recalled for attachment failure risk
What this means
The Bravo CF capsule delivery device is used during esophageal pH monitoring procedures to attach a small capsule to the esophagus. The capsule may fail to attach properly or detach from the delivery device during use. This can result in the capsule being inhaled, perforating the esophagus, blocking the airway, or causing bleeding.
- If you are a healthcare facility using this device, contact Given Imaging Ltd. for instructions on affected lot numbers (64553F through 68912F with expiration dates on or before October 20, 2027).
- Do not use affected units for new procedures.
- If a patient has undergone a procedure with this device and experiences chest pain, difficulty swallowing, vomiting blood, or breathing problems, seek immediate medical attention.
The agency's original wording
Capsule may fail to attach to the esophagus or detach from the delivery device. Risks include patient aspiration/inhalation, perforation of esophagus, obstruction of the airway, hemorrhage/blood loss/bleeding, laceration of the esophagus, a delay in diagnosis, and foreign bodies remaining in the patient.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-3090-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.